Home » Newsletters » BioWorld

BioWorld

Oct. 25, 1991

View Archived Issues

IVAX CANCELS NOVEN ACQUISITION

PATENT FLASH !

S.R. ONE EXERCISES RIBI WARRANTS

$1.27M GRANT FOR TAXOL STUDY

GM-CSF HELPS IMMUNEX TO PROFITABLE QUARTER

IMCLONE FILES FOR 2 MILLION-SHARE IPO

BCG SHOWS PROMISE AGAINST BLADDER CANCER

OXFORD, FAIRFIELD PLAN BIOSCIENCE FUND

ANALYST LOWERS AMGEN RATING

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026